CONSOLIDATED BALANCE SHEETS (UNAUDITED) - EUR (€) € in Thousands	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash	€ 598	€ 479
Receivables	190	585
Prepaid expenses	44	37
Total current assets	832	1,101
Property and equipment, net of accumulated depreciation of E444 at June 30, 2019 and E434 at December 31, 2018	26	36
Goodwill	6,671	6,671
Total assets	7,529	7,808
Current Liabilities
Accounts payable	48	75
Non-convertible notes payable and related accrued interest to related parties	4,651	4,002
Convertible notes payable and related accrued interest to related parties	52,057	50,756
Total liabilities	56,756	54,833
Shareholders' Equity (Deficit)
Common stock, U.S. $0.01 par value; 1,000,000,000 shares authorized; issued and outstanding 303,757,622 at June 30, 2019 and at December 31, 2018	2,530	2,530
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	34,443	34,441
Accumulated deficit	(86,885)	(84,675)
Accumulated other comprehensive income	685	679
Total shareholders' equity (deficit)	(49,227)	(47,025)
Total liabilities and shareholders' equity (deficit)	€ 7,529	€ 7,808

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580